Comparison of SARS-CoV-2 variants in primary human nasal cultures indicates Delta as most cytopathic and Omicron as fastest replicating
暂无分享,去创建一个
Brendan J. Kelly | Nikhila S Tanneti | F. Bushman | Ranawaka A.P.M Perera | N. Cohen | S. Weiss | R. Collman | K. Rodino | S. Sherrill-Mix | Andrew D Marques | L. Tan | Anant K. Patel | Carole Lee
[1] Jyoti R. Yemul,et al. Comparative pathogenicity of BA.2.12, BA.5.2 and XBB.1 with the Delta variant in Syrian hamsters , 2023, Frontiers in microbiology.
[2] Sean J. Humphrey,et al. Parallel use of human stem cell lung and heart models provide insights for SARS-CoV-2 treatment , 2023, Stem cell reports.
[3] N. Cohen,et al. Infection of primary nasal epithelial cells differentiates among lethal and seasonal human coronaviruses , 2023, Proceedings of the National Academy of Sciences of the United States of America.
[4] T. Mokhtari-azad,et al. The reproduction rate of severe acute respiratory syndrome coronavirus 2 different variants recently circulated in human: a narrative review , 2023, European Journal of Medical Research.
[5] William T. Harvey,et al. SARS-CoV-2 variant biology: immune escape, transmission and fitness , 2023, Nature Reviews Microbiology.
[6] A. Awasthi,et al. Intrinsic D614G and P681R/H mutations in SARS-CoV-2 VoCs Alpha, Delta, Omicron and viruses with D614G plus key signature mutations in spike protein alters fusogenicity and infectivity , 2022, Medical Microbiology and Immunology.
[7] Wassan Nori,et al. Omicron targets upper airways in pediatrics, elderly and unvaccinated population , 2022, World journal of clinical cases.
[8] S. Vashee,et al. A neonatal mouse model characterizes transmissibility of SARS-CoV-2 variants and reveals a role for ORF8 , 2022, bioRxiv.
[9] S. Subramaniam,et al. SARS-CoV-2 variants of concern: spike protein mutational analysis and epitope for broad neutralization , 2022, Nature Communications.
[10] Christian J. H. von Wintersdorff,et al. Infections with the SARS-CoV-2 Delta variant exhibit fourfold increased viral loads in the upper airways compared to Alpha or non-variants of concern , 2022, Scientific Reports.
[11] William T. Harvey,et al. SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway , 2022, Nature Microbiology.
[12] W. Baumgärtner,et al. SARS-CoV-2 Omicron variant causes mild pathology in the upper and lower respiratory tract of hamsters , 2022, Nature Communications.
[13] T. Blundell,et al. In silico analysis of mutations near S1/S2 cleavage site in SARS‐CoV‐2 spike protein reveals increased propensity of glycosylation in Omicron strain , 2022, Journal of medical virology.
[14] Arvind H. Patel,et al. The altered entry pathway and antigenic distance of the SARS-CoV-2 Omicron variant map to separate domains of spike protein , 2022, bioRxiv.
[15] E. Klein,et al. The displacement of the SARS-CoV-2 variant Delta with Omicron: An investigation of hospital admissions and upper respiratory viral loads , 2022, eBioMedicine.
[16] A. Huppert,et al. Viral load dynamics of SARS-CoV-2 Delta and Omicron variants following multiple vaccine doses and previous infection , 2022, Nature Communications.
[17] D. Dean,et al. SARS-CoV-2 variants of concern Alpha and Delta show increased viral load in saliva , 2022, medRxiv.
[18] M. Diamond,et al. Innate immunity: the first line of defense against SARS-CoV-2 , 2022, Nature Immunology.
[19] Frances E. Muldoon,et al. Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity , 2022, Nature.
[20] M. Wass,et al. Reduced interferon antagonism but similar drug sensitivity in Omicron variant compared to Delta variant of SARS-CoV-2 isolates , 2022, Cell Research.
[21] D. Purcell,et al. Air-Liquid-Interface Differentiated Human Nose Epithelium: A Robust Primary Tissue Culture Model of SARS-CoV-2 Infection , 2022, International journal of molecular sciences.
[22] Vineet D. Menachery,et al. QTQTN motif upstream of the furin-cleavage site plays a key role in SARS-CoV-2 infection and pathogenesis , 2021, bioRxiv.
[23] Brendan J. Kelly,et al. SARS-CoV-2 variants associated with vaccine breakthrough in the Delaware Valley through summer 2021 , 2021, medRxiv.
[24] E. Frolova,et al. Natural and Recombinant SARS-CoV-2 Isolates Rapidly Evolve In Vitro to Higher Infectivity through More Efficient Binding to Heparan Sulfate and Reduced S1/S2 Cleavage , 2021, Journal of virology.
[25] Vineet D. Menachery,et al. Delta spike P681R mutation enhances SARS-CoV-2 fitness over Alpha variant , 2021, bioRxiv.
[26] G. Whittaker. SARS-CoV-2 spike and its adaptable furin cleavage site , 2021, The Lancet Microbe.
[27] D. Meyerholz,et al. The TMPRSS2 Inhibitor Nafamostat Reduces SARS-CoV-2 Pulmonary Infection in Mouse Models of COVID-19 , 2021, mBio.
[28] O. Pybus,et al. Assignment of epidemiological lineages in an emerging pandemic using the pangolin tool , 2021, Virus evolution.
[29] S. Boulant,et al. TMPRSS2 expression dictates the entry route used by SARS‐CoV‐2 to infect host cells , 2021, The EMBO journal.
[30] S. Maurer-Stroh,et al. Clinical and Virological Features of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants of Concern: A Retrospective Cohort Study Comparing B.1.1.7 (Alpha), B.1.351 (Beta), and B.1.617.2 (Delta) , 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[31] D. Qu,et al. A genome-wide CRISPR screen identifies host factors that regulate SARS-CoV-2 entry , 2021, Nature Communications.
[32] Vineet D. Menachery,et al. Loss of furin cleavage site attenuates SARS-CoV-2 pathogenesis , 2021, Nature.
[33] M. Kiso,et al. The Anticoagulant Nafamostat Potently Inhibits SARS-CoV-2 S Protein-Mediated Fusion in a Cell Fusion Assay System and Viral Infection In Vitro in a Cell-Type-Dependent Manner , 2020, Viruses.
[34] Neva C. Durand,et al. A rapid, low-cost, and highly sensitive SARS-CoV-2 diagnostic based on whole-genome sequencing , 2020, bioRxiv.
[35] G. Herrler,et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor , 2020, Cell.
[36] S. Weiss,et al. Neurovirulent Murine Coronavirus JHM.SD Uses Cellular Zinc Metalloproteases for Virus Entry and Cell-Cell Fusion , 2017, Journal of Virology.
[37] Fang Li,et al. Structure, Function, and Evolution of Coronavirus Spike Proteins. , 2016, Annual review of virology.
[38] J. Palmer,et al. Bitter and sweet taste receptors regulate human upper respiratory innate immunity. , 2014, The Journal of clinical investigation.
[39] G. Whittaker,et al. Mechanisms of Coronavirus Cell Entry Mediated by the Viral Spike Protein , 2012, Viruses.
[40] S. Weiss,et al. Endosomal Proteolysis by Cathepsins Is Necessary for Murine Coronavirus Mouse Hepatitis Virus Type 2 Spike-Mediated Entry , 2006, Journal of Virology.
[41] T A Wyatt,et al. All‐digital image capture and whole‐field analysis of ciliary beat frequency , 2003, Journal of microscopy.
[42] Jing Liu,et al. Human Nasal Epithelial Cells (hNECs ) Generated by Air-Liquid Interface (ALI) Culture as a Model System for Studying the Pathogenesis of SARS-CoV-2. , 2022, Methods in molecular biology.